产品: E2F1 抗体
货号: AF6377
描述: Rabbit polyclonal antibody to E2F1
应用: WB IF/ICC
反应: Human, Mouse
预测: Pig, Bovine, Horse, Rabbit, Chicken
分子量: 47kDa; 47kD(Calculated).
蛋白号: Q01094
RRID: AB_2835219

浏览相似产品>>

   规格 价格 库存
 50ul RMB¥ 1250 现货
 100ul RMB¥ 2300 现货
 200ul RMB¥ 3000 现货

货期: 当天发货

联系销售

产品描述

来源:
Rabbit
应用:
WB 1:500-1:2000, IF/ICC 1:100-1:500
*The optimal dilutions should be determined by the end user.
*Tips:

WB: 适用于变性蛋白样本的免疫印迹检测. IHC: 适用于组织样本的石蜡(IHC-p)或冰冻(IHC-f)切片样本的免疫组化/荧光检测. IF/ICC: 适用于细胞样本的荧光检测. ELISA(peptide): 适用于抗原肽的ELISA检测.

反应:
Human,Mouse
预测:
Pig(100%), Bovine(100%), Horse(100%), Rabbit(100%), Chicken(82%)
克隆:
Polyclonal
特异性:
E2F1 Antibody detects endogenous levels of total E2F1.
RRID:
AB_2835219
引用格式: Affinity Biosciences Cat# AF6377, RRID:AB_2835219.
偶联:
Unconjugated.
纯化:
The antiserum was purified by peptide affinity chromatography using SulfoLink™ Coupling Resin (Thermo Fisher Scientific).
保存:
Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at -20 °C. Stable for 12 months from date of receipt.
别名:

展开/折叠

Dmel\CG6376; Dmel_CG6376; drosE2F1; E(Sev-CycE)3A; E(var)3-93E; E2-promoter binding facto; E2F 1; E2F transcription factor 1; E2F-1; E2f-PA; E2f-PB; E2f-PC; E2F1; E2f1 E2F transcription factor 1; E2F1_HUMAN; Evar(3)164; KIAA4009; l(3)07172; l(3)j3B1; l(3)j3C2; l(3)rM729; mKIAA4009; OTTHUMP00000030661; PBR3; PRB binding protein E2F 1; PRB-binding protein E2F-1; RBAP 1; RBAP-1; RBAP1; RBBP-3; RBBP3; RBP 3; RBP3; Retinoblastoma-associated protein 1; Retinoblastoma-binding protein 3; Transcription factor E2F1;

抗原和靶标

免疫原:
Uniprot:
基因/基因ID:
描述:
The protein encoded by this gene is a member of the E2F family of transcription factors. The E2F family plays a crucial role in the control of cell cycle and action of tumor suppressor proteins and is also a target of the transforming proteins of small DNA tumor viruses.
序列:
MALAGAPAGGPCAPALEALLGAGALRLLDSSQIVIISAAQDASAPPAPTGPAAPAAGPCDPDLLLFATPQAPRPTPSAPRPALGRPPVKRRLDLETDHQYLAESSGPARGRGRHPGKGVKSPGEKSRYETSLNLTTKRFLELLSHSADGVVDLNWAAEVLKVQKRRIYDITNVLEGIQLIAKKSKNHIQWLGSHTTVGVGGRLEGLTQDLRQLQESEQQLDHLMNICTTQLRLLSEDTDSQRLAYVTCQDLRSIADPAEQMVMVIKAPPETQLQAVDSSENFQISLKSKQGPIDVFLCPEETVGGISPGKTPSQEVTSEEENRATDSATIVSPPPSSPPSSLTTDPSQSLLSLEQEPLLSRMGSLRAPVDEDRLSPLVAADSLLEHVREDFSGLLPEEFISLSPPHEALDYHFGLEEGEGIRDLFDCDFGDLTPLDF

种属预测

种属预测:

score>80的预测可信度较高,可尝试用于WB检测。*预测模型主要基于免疫原序列比对,结果仅作参考,不作为质保凭据。

Species
Results
Score
Pig
100
Horse
100
Bovine
100
Rabbit
100
Chicken
82
Zebrafish
73
Sheep
0
Dog
0
Xenopus
0
Model Confidence:
High(score>80) Medium(80>score>50) Low(score<50) No confidence

翻译修饰 - Q01094 作为底物

Site PTM Type Enzyme
Phosphorylation
S31 Phosphorylation Q13315 (ATM) , Q13535 (ATR)
T96 Phosphorylation
R109 Methylation
R111 Methylation
R113 Methylation
K117 Acetylation
K120 Acetylation
S121 Phosphorylation
K125 Acetylation
T135 Phosphorylation
T136 Phosphorylation
K161 Ubiquitination
K164 Ubiquitination
K185 Methylation
S307 Phosphorylation
S332 Phosphorylation Q9UHD2 (TBK1) , P06493 (CDK1)
S337 Phosphorylation P06493 (CDK1) , O43318 (MAP3K7)
S364 Phosphorylation O96017 (CHEK2) , P49137 (MAPKAPK2) , Q683Z8 (CHK2)
S375 Phosphorylation P49336 (CDK8)
S403 Phosphorylation P32780 (GTF2H1) , P49841 (GSK3B) , Q15759 (MAPK11) , O15111 (CHUK) , P50613 (CDK7)
T433 Phosphorylation P49841 (GSK3B) , P32780 (GTF2H1) , P50613 (CDK7) , Q15759 (MAPK11)

研究背景

功能:

Transcription activator that binds DNA cooperatively with DP proteins through the E2 recognition site, 5'-TTTC[CG]CGC-3' found in the promoter region of a number of genes whose products are involved in cell cycle regulation or in DNA replication. The DRTF1/E2F complex functions in the control of cell-cycle progression from G1 to S phase. E2F1 binds preferentially RB1 in a cell-cycle dependent manner. It can mediate both cell proliferation and TP53/p53-dependent apoptosis. Blocks adipocyte differentiation by binding to specific promoters repressing CEBPA binding to its target gene promoters. Positively regulates transcription of RRP1B.

翻译修饰:

Phosphorylated by CDK2 and cyclin A-CDK2 in the S-phase. Phosphorylation at Ser-364 by CHEK2 stabilizes E2F1 upon DNA damage and regulates its effect on transcription and apoptosis.

Acetylation stimulates DNA-binding. Enhanced under stress conditions such as DNA damage and inhibited by retinoblastoma protein RB1. Regulated by KAP1/TRIM28 which recruits HDAC1 to E2F1 resulting in deacetylation. Acetylated by P/CAF/KAT2B.

细胞定位:

Nucleus.

Extracellular region or secreted Cytosol Plasma membrane Cytoskeleton Lysosome Endosome Peroxisome ER Golgi apparatus Nucleus Mitochondrion Manual annotation Automatic computational assertionSubcellular location
亚基结构:

Component of the DRTF1/E2F transcription factor complex. Forms heterodimers with DP family members. The E2F1 complex binds specifically hypophosphorylated retinoblastoma protein RB1. During the cell cycle, RB1 becomes phosphorylated in mid-to-late G1 phase, detaches from the DRTF1/E2F complex, rendering E2F transcriptionally active. Viral oncoproteins, notably E1A, T-antigen and HPV E7, are capable of sequestering RB1, thus releasing the active complex. Interacts with TRRAP, which probably mediates its interaction with histone acetyltransferase complexes, leading to transcription activation. Binds TOPBP1 and EAPP. Interacts with ARID3A. Interacts with TRIM28; the interaction inhibits E2F1 acetylation through recruiting HDAC1 and represses its transcriptional activity. Interaction with KAT2B; the interaction acetylates E2F1 enhancing its DNA-binding and transcriptional activity. Interacts with BIRC2/c-IAP1 (via BIR domains). The complex TFDP1:E2F1 interacts with CEBPA; the interaction prevents CEBPA binding to target genes promoters and represses its transcriptional activity. Interacts with RRP1B. Interacts with HCFC1. Interacts with KMT2E; the interaction is probably indirect and is mediated via HCFC1.

(Microbial infection) Interacts with human cytomegalovirus/HHV-5 protein UL123.

蛋白家族:

Belongs to the E2F/DP family.

研究领域

· Cellular Processes > Cell growth and death > Cell cycle.   (View pathway)

· Cellular Processes > Cell growth and death > Cellular senescence.   (View pathway)

· Human Diseases > Drug resistance: Antineoplastic > Endocrine resistance.

· Human Diseases > Infectious diseases: Viral > Hepatitis B.

· Human Diseases > Infectious diseases: Viral > Human papillomavirus infection.

· Human Diseases > Infectious diseases: Viral > HTLV-I infection.

· Human Diseases > Cancers: Overview > Pathways in cancer.   (View pathway)

· Human Diseases > Cancers: Overview > MicroRNAs in cancer.

· Human Diseases > Cancers: Specific types > Pancreatic cancer.   (View pathway)

· Human Diseases > Cancers: Specific types > Glioma.   (View pathway)

· Human Diseases > Cancers: Specific types > Prostate cancer.   (View pathway)

· Human Diseases > Cancers: Specific types > Melanoma.   (View pathway)

· Human Diseases > Cancers: Specific types > Bladder cancer.   (View pathway)

· Human Diseases > Cancers: Specific types > Chronic myeloid leukemia.   (View pathway)

· Human Diseases > Cancers: Specific types > Small cell lung cancer.   (View pathway)

· Human Diseases > Cancers: Specific types > Non-small cell lung cancer.   (View pathway)

· Human Diseases > Cancers: Specific types > Breast cancer.   (View pathway)

· Human Diseases > Cancers: Specific types > Hepatocellular carcinoma.   (View pathway)

· Human Diseases > Cancers: Specific types > Gastric cancer.   (View pathway)

文献引用

1). Gambogic acid sensitizes gemcitabine efficacy in pancreatic cancer by reducing the expression of ribonucleotide reductase subunit-M2 (RRM2). Journal of Experimental & Clinical Cancer Research (PubMed: 28797284) [IF=11.3]

Application: WB    Species: human    Sample:

Fig. 7 Gambogic acid (GA) reduces the expression of ribonucleotide reductase subunit-M2 (RRM2) by inhibiting the ERK/E2F1 signaling pathway. a PANC-1 and BxPC-3 cells were treated with 1, 2, and 4 μM GA for 24 h, respectively. Protein levels of RRM2 and E2F1 were detected using western blot analysis. b, c PANC-1 and BxPC-3 cells were treated with si-E2F1 for 48 h, and protein levels of RRM2 and E2F1 were detected using western blot analysis (b); the mRNA levels of RRM2 and E2F1 were detected by q-PCR (C). (D, E) PANC-1 and BxPC-3 cells were treated with 1 μM GA or 5 μM gemcitabine alone, or in combination (GA with gemcitabine) for 24 h. Expression of the p-ERK, ERK, E2F1 and RRM2 proteins were detected using western blot analysis and q-PCR (d).

2). Isoliquiritigenin suppresses the progression of malignant melanoma via targeting H2A.Z.1-E2F1 pathway. Biochemical pharmacology (PubMed: 37863326) [IF=5.8]

Application: WB    Species: Human    Sample: A375 and SK-MEL-28 cell

Fig. 6. E2F1 was identified as one target of H2A.Z.1. (A) Analysis of the downstream transcription factors of the co-expressed genes significantly associated with H2AFZ (encoding H2A.Z.1) based on LinkedOmics database. (B) Expression correlation of H2AFZ and E2F1 by GSEA transcriptional regulation analysis. (C) Correlation analysis between mRNA expression of H2A.Z.1 and E2F1. (D) With or without ISL administration for 48 h, the expression of E2F1 in two cell lines (A375 and SK-MEL-28) transfected with empty vector or H2A.Z.1-overexpressed plasmid were detected by western blot. (E) The expression level of E2F1 in SKCM and normal tissues based on TCGA database. (F) The overall survival and progression-free survival (PFS) time in patients with high and low expression of E2F1. The data represented the mean ± SEM of three independent experiments, *P < 0.05, **P < 0.01, ***P < 0.001, ns: not significant.

3). Indoxyl sulfate promotes the atherosclerosis through up-regulating the miR-34a expression in endothelial cells and vascular smooth muscle cells in vitro. VASCULAR PHARMACOLOGY (PubMed: 32593718) [IF=4.0]

Application: WB    Species: human    Sample: HUVECs and HA-VSMCs

Fig. 7.| IS inhibits the Notch signaling pathway and miR-34a-related protein. After transfection with miR-34a mimics (50 nM) or inhibitor (100 nM), IS (1000 μM) was added and incubated for another 36 h. Western blotting was used to detected the protein expression in HUVECs and HA-VSMCs. Data are represented as the mean ± SEM (n = 3). ⁎P < .05, versus control, #P < .05, versus IS group by one-way ANOVA with Tukey's test

4). Columbianetin acetate inhibits the occurrence and development of pancreatic cancer cells by down-regulating the expression of Meiotic nuclear divisions 1.. Biocell [IF=1.2]

5). Expression Profiles of HOXC6 Predict the Survival of Glioblastoma Patients and Correlate with Cell Cycle. Journal of Oncology (PubMed: 35432534)

Application: WB    Species: Human    Sample: LN229 cells

Figure 5 Tumor cell biology experiments of HOXC6. (a) Expression of HOXC6 after transfection of siRNA or overexpression plasmid measured by PCR. (b) CCK-8 assay to evaluate the effect of HOXC6 knockdown or overexpression on cell proliferation in LN229 cells. ∗p < 0.05, ∗∗p < 0.01. (c) CCK-8 assay to evaluate the effect of HOXC6 knockdown or overexpression on cell proliferation in T98G cells. From left to right: NC, OE, and SI. (d) Flow cytometry analysis to evaluate the effects of HOXC6 on cell cycle progression in LN229 cells. (e) Flow cytometry analysis to evaluate the effects of HOXC6 on cell cycle progression in T98G cells. From left to right: NC, OE, and SI. (f) Western blot analysis to evaluate the effects of HOXC6 on expression level of cell cycle related proteins.

限制条款

产品的规格、报价、验证数据请以官网为准,官网链接:www.affbiotech.com | www.affbiotech.cn(简体中文)| www.affbiotech.jp(日本語)

产品的数据信息为Affinity所有,未经授权不得收集Affinity官网数据或资料用于商业用途,对抄袭产品数据的行为我们将保留诉诸法律的权利。

产品相关数据会因产品批次、产品检测情况随时调整,如您已订购该产品,请以订购时随货说明书为准,否则请以官网内容为准,官网内容有改动时恕不另行通知。

Affinity保证所销售产品均经过严格质量检测。如您购买的商品在规定时间内出现问题需要售后时,请您在Affinity官方渠道提交售后申请。

产品仅供科学研究使用。不用于诊断和治疗。 

产品未经授权不得转售。

Affinity Biosciences将不会对在使用我们的产品时可能发生的专利侵权或其他侵权行为负责。Affinity Biosciences, Affinity Biosciences标志和所有其他商标所有权归Affinity Biosciences LTD.